The automatic detection of Alzheimer's disease (AD) using 3D volumetric MRI data is a complex, multi-domain challenge that has traditionally been addressed by training classical convolutional neural networks (CNNs). With the rise of quantum computing and its potential to replace classical systems in the future, there is a growing need to: (i) develop automated systems for AD detection that run on quantum computers, (ii) explore the capabilities of current-generation classical-quantum architectures, and (iii) identify their potential limitations and advantages. To reduce the complexity of multi-domain expertise while addressing the emerging demands of quantum-based automated systems, our contribution in this paper is twofold. First, we introduce a simple preprocessing framework that converts 3D MRI volumetric data into 2D slices. Second, we propose CQ-CNN, a parameterized quantum circuit (PQC)-based lightweight hybrid classical-quantum convolutional neural network that leverages the computational capabilities of both classical and quantum systems. Our experiments on the OASIS-2 dataset reveal a significant limitation in current hybrid classical-quantum architectures, as they face difficulties converging when class images are highly similar, such as between moderate dementia and non-dementia classes of AD, which leads to gradient failure and optimization stagnation. However, when convergence is achieved, the quantum model demonstrates a promising quantum advantage by attaining state-of-the-art accuracy with far fewer parameters than classical models. For instance, our [Formula: see text]-3-qubit model achieves 97.5% accuracy using only 13.7K parameters (0.05 MB), which is 5.67% higher than a classical model with the same parameter count. Nevertheless, our results highlight the need for improved quantum optimization methods to support the practical deployment of hybrid classical-quantum models in AD detection and related medical imaging tasks.
Copyright: © 2025 Islam et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.